Skip to main content
Fig. 3 | Thrombosis Journal

Fig. 3

From: Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab

Fig. 3

TMA/aHUS score at baseline and after eculizumab treatment. Each box represents the lower (Q1), median (Q2) and the upper (Q3) quartile respectively, and each bar represents data range in each group. Solid horizontal line indicates the diagnostic cutoff value of 5. Changes from baseline were compared using Wilcoxon rank sum test *p < 0.001. Abbreviations: aHUS, atypical hemolytic uremic syndrome; TMA, thrombotic microangiopathy

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us